Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FIND Neuro (officially FIND Surgical Sciences, Inc.) is a digital health and neurotechnology company that develops an AI-powered clinical decision-support platform for precision neurology, with a primary focus on drug-resistant epilepsy surgery. Spun out of Massachusetts General Hospital and Harvard Medical School, the company's flagship platform, CN-Suite, integrates raw neuroimaging and electrophysiology data—including MRI, CT, and sEEG recordings—into a patient-specific 3D brain model. By utilizing its proprietary Critical Nodes algorithm, the technology identifies the network drivers of seizures, providing surgeons with objective evidence to perform more precise and effective interventions. Beyond epilepsy, FIND Neuro is expanding its network analysis engine to guide precision neuromodulation and other bioelectronic therapies. The company's solutions aim to improve surgical success rates and patient outcomes for those suffering from complex neurological disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FIND Neuro.